TY - JOUR T1 - How to use nesiritide in treating decompensated heart failure JF - Cleveland Clinic Journal of Medicine JO - Cleve Clin J Med SP - 252 LP - 256 VL - 69 IS - 3 AU - Roger M. Mills AU - Robert E. Hobbs Y1 - 2002/03/01 UR - http://www.ccjm.org/content/69/3/252.abstract N2 - Nesiritide (Natrecor), a synthetic formulation of B-type natriuretic peptide (BNP), is the first new parenteral agent to be approved for treating heart failure in more than a decade. In patients hospitalized with decompensated congestive heart failure, nesiritide promptly reduces pulmonary capillary wedge pressure, pulmonary arterial pressure, right atrial pressure, and systemic vascular resistance, resulting in clinical improvement. ER -